152 related articles for article (PubMed ID: 3411819)
1. Calcium antagonistic effects and the in vitro duration of actions of KW-3049, a new 1,4-dihydropyridine derivative, in isolated canine coronary arteries.
Karasawa A; Kubo K
Jpn J Pharmacol; 1988 May; 47(1):35-44. PubMed ID: 3411819
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological actions of benidipine hydrochloride in several isolated smooth muscles and myocardium.
Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1722-30. PubMed ID: 3219148
[TBL] [Abstract][Full Text] [Related]
3. Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists.
Nakaya H; Hattori Y; Nakao Y; Kanno M
Eur J Pharmacol; 1988 Jan; 146(1):35-43. PubMed ID: 3350058
[TBL] [Abstract][Full Text] [Related]
4. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
[TBL] [Abstract][Full Text] [Related]
5. Differential antagonism by Bay k 8644, a dihydropyridine calcium agonist, of the negative inotropic effects of nifedipine, verapamil, diltiazem and manganese ions in canine ventricular muscle.
Ishii K; Taira N; Yanagisawa T
Br J Pharmacol; 1985 Feb; 84(2):577-84. PubMed ID: 2579702
[TBL] [Abstract][Full Text] [Related]
6. Effects of nilvadipine on the cardiovascular system in experimental animals.
Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
[TBL] [Abstract][Full Text] [Related]
7. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
Kanda M; Shirahase H; Kurahashi K; Wada K; Nakamura S; Matsui H; Fukata F
Arzneimittelforschung; 1995 Aug; 45(8):831-5. PubMed ID: 7575741
[TBL] [Abstract][Full Text] [Related]
8. Nitrendipine: effects on vascular responses and myocardial binding.
McBride W; Mukherjee A; Haghani Z; Wheeler-Clark E; Brady J; Gandler T; Bush L; Buja LM; Willerson JT
Am J Physiol; 1984 Nov; 247(5 Pt 2):H775-83. PubMed ID: 6093595
[TBL] [Abstract][Full Text] [Related]
9. Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles.
Nishimura K; Miyawaki N; Yamauchi H; Iso T
Arzneimittelforschung; 1990 Mar; 40(3):244-8. PubMed ID: 2112000
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
11. Assessment in pig coronary artery of long-lasting and potent calcium antagonistic actions of the novel dihydropyridine derivative mepirodipine hydrochloride.
Nakayama K; Kashiwabara T; Yamada S; Tanaka Y
Arzneimittelforschung; 1989 Jan; 39(1):50-5. PubMed ID: 2470382
[TBL] [Abstract][Full Text] [Related]
12. Effect of MCI-176, a new calcium antagonist, on the calcium induced contraction of isolated porcine coronary arteries.
Ishibashi A; Horii D
Jpn J Pharmacol; 1987 Feb; 43(2):234-6. PubMed ID: 3573428
[TBL] [Abstract][Full Text] [Related]
13. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
[TBL] [Abstract][Full Text] [Related]
14. Verapamil, diltiazem and nifedipine block the depolarization-induced potentiation of norepinephrine contractions in rabbit aorta and porcine coronary arteries.
Hondeghem LM; Ayad MJ; Robertson RM
J Pharmacol Exp Ther; 1986 Dec; 239(3):808-13. PubMed ID: 3795042
[TBL] [Abstract][Full Text] [Related]
15. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.
Winquist RJ; Siegl PK; Baskin EP; Bohn DL; Morgan G; Wallace AA
J Pharmacol Exp Ther; 1984 Jul; 230(1):103-9. PubMed ID: 6747822
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea-pig hearts.
Boddeke HW; Wilffert B; Heynis JB; van de Haar Keuken V; Jonkman FA; van Zwieten PA
Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):175-85. PubMed ID: 3675080
[TBL] [Abstract][Full Text] [Related]
17. Myocardial and vascular effects of efonidipine in vitro as compared with nifedipine, verapamil and diltiazem.
Tanaka H; Masumiya H; Sekine T; Sijuku T; Sugahara M; Taniguchi H; Terada M; Saito W; Shigenobu K
Gen Pharmacol; 1996 Apr; 27(3):451-4. PubMed ID: 8723524
[TBL] [Abstract][Full Text] [Related]
18. Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats.
Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1707-12. PubMed ID: 3219145
[TBL] [Abstract][Full Text] [Related]
19. Effects of nitroglycerin, dipyridamole, nifedipine, verapamil and diltiazem on canine coronary arterial rings contracted with 5-hydroxytryptamine and anoxia.
Barrett JA; DePaul Lynch V; Balkon J; Smith RD; Wolf PS
Pharmacology; 1986; 33(3):139-47. PubMed ID: 3092250
[TBL] [Abstract][Full Text] [Related]
20. Abolition of spontaneous rhythmic contractions of isolated monkey coronary arteries by diltiazem, nifedipine, verapamil and nicorandil but not by nitroglycerin.
Ishii K; Yanagisawa T; Satoh K; Taira N
Tohoku J Exp Med; 1985 Jan; 145(1):85-90. PubMed ID: 3157242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
